Cetera Investment Advisers grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by

Assenagon Asset Management S.A. lifted its holdings in Teva Pharmaceutical Industries Ltd. (NYSE: TE

Investors with an interest in Medical - Generic Drugs stocks have likely encountered both Supernus P

Teva Pharmaceuticals has asked a U.S. judge to ​prevent insurer Humana from telling jurors it is an

Teva Pharmaceutical Industries Limited is executing a successful turnaround, driven by its "Pivot to

Teva Pharmaceutical is undergoing a transformation, shifting its revenue mix toward specialty and in

Teva posted its Q2 results this week, reporting an earnings miss even though sales beat expectations

Avidity Partners Management LP increased its holdings in shares of Teva Pharmaceutical Industries Lt

Axiom Investment Management LLC purchased a new position in Teva Pharmaceutical Industries Ltd. (NYS

TEVA misses Q2 earnings estimates as Emalex acquisition costs weigh on profits, while innovative dru

Teva Pharmaceutical Industries NYSE: TEVA reported second-quarter 2026 revenue of approximately $4.1

Teva Pharmaceutical Industries Limited (TEVA) Q2 2026 Earnings Call Transcript

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) stock is trading higher on Wednesday after the compa

Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its busin

MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Euronext Paris: MEDCL) partner, Teva Pharmaceutical

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Euronext Paris: MEDCL) partner, Te

Besides Wall Street's top-and-bottom-line estimates for Teva Pharmaceutical Industries (TEVA), revie

Teva's pivot toward branded drugs is benefiting the company's underlying performance and its stock p

Teva's business is shifting away from generic drugs toward branded drugs. Operating margins could so

Bank of New York Mellon Corp cut its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE: T

Bill Ackman is bullish on Israel. Here's why he thinks investors should watch the region.

Teva will advance TEV-'408 into a Phase 2b vitiligo study after Phase 1b data showed skin pigmen

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men

Axsome gains after securing global rights to balipodect from Takeda, advancing schizophrenia pipelin

Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering r

Teva and Royalty Pharma have signed a deal worth up to $500 million to advance TEV-408, a drug being

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at

U.S. stocks experienced a drop as of midday trading in New York, potentially ending a prolonged stre

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks o

As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is likely to report earnings for its four

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

Gainers